640 related articles for article (PubMed ID: 22607850)
1. A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.
Krum H; Lemke B; Birnie D; Lee KL; Aonuma K; Starling RC; Gasparini M; Gorcsan J; Rogers T; Sambelashvili A; Kalmes A; Martin D
Am Heart J; 2012 May; 163(5):747-752.e1. PubMed ID: 22607850
[TBL] [Abstract][Full Text] [Related]
2. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial.
Martin DO; Lemke B; Birnie D; Krum H; Lee KL; Aonuma K; Gasparini M; Starling RC; Milasinovic G; Rogers T; Sambelashvili A; Gorcsan J; Houmsse M;
Heart Rhythm; 2012 Nov; 9(11):1807-14. PubMed ID: 22796472
[TBL] [Abstract][Full Text] [Related]
3. Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials.
Singh JP; Abraham WT; Chung ES; Rogers T; Sambelashvili A; Coles JA; Martin DO
Europace; 2013 Nov; 15(11):1622-8. PubMed ID: 24014804
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial.
Birnie D; Lemke B; Aonuma K; Krum H; Lee KL; Gasparini M; Starling RC; Milasinovic G; Gorcsan J; Houmsse M; Abeyratne A; Sambelashvili A; Martin DO
Heart Rhythm; 2013 Sep; 10(9):1368-74. PubMed ID: 23851059
[TBL] [Abstract][Full Text] [Related]
5. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy.
Abraham WT; León AR; St John Sutton MG; Keteyian SJ; Fieberg AM; Chinchoy E; Haas G
Am Heart J; 2012 Nov; 164(5):735-41. PubMed ID: 23137504
[TBL] [Abstract][Full Text] [Related]
7. Continuously adjusting CRT therapy: clinical impact of adaptive cardiac resynchronization therapy.
Houmsse M; Abraham WT
Expert Rev Cardiovasc Ther; 2014 May; 12(5):541-8. PubMed ID: 24678730
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial.
Abraham WT; Gras D; Yu CM; Guzzo L; Gupta MS;
Am Heart J; 2010 Jun; 159(6):944-948.e1. PubMed ID: 20569704
[TBL] [Abstract][Full Text] [Related]
10. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
[TBL] [Abstract][Full Text] [Related]
11. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
Birnie D; Hudnall H; Lemke B; Aonuma K; Lee KL; Gasparini M; Gorcsan J; Cerkvenik J; Martin DO
Heart Rhythm; 2017 Dec; 14(12):1820-1825. PubMed ID: 28893549
[TBL] [Abstract][Full Text] [Related]
12. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
13. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial).
Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
16. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
17. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
[TBL] [Abstract][Full Text] [Related]
19. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.
Sims DB; Mignatti A; Colombo PC; Uriel N; Garcia LI; Ehlert FA; Jorde UP
Europace; 2011 Oct; 13(10):1459-63. PubMed ID: 21551475
[TBL] [Abstract][Full Text] [Related]
20. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
